The published evidence generated from the cellular models for the Luminal A subtype [11,12,13] and the TNBC subtype [11,12,13,14,15,16] provide mechanistic leads for the efficacy of Chinese herbs in breast cancer subtypes that differ in their status of hormone receptors. Here, NR4A1 is linked to breast carcinoma.